IOC launches call for medal designs for Dakar 2026 Youth Olympic Games
02 September 2025 - Creatives and Olympic fans now have the chance…
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented…
PureTech Health plc Half-Year Report
Achieved meaningful progress toward key value inflection points across our diversified portfolio,…
AI adoption is strong among entry-level workers across sectors and economies – and it’s making work life easier and more enjoyable, reports Generation
Analysis finds that 65% of entry-level employees are using AI, and most…
Scott+Scott, Robins Kaplan, Hausfeld Reach Agreement with Greystar for Significant Monetary Relief and Important Business Reforms
SAN DIEGO--(BUSINESS WIRE)--The law firms of Scott+Scott, Robins Kaplan, and Hausfeld have…
Zoomlion Advances Global Localization Through Community Action, Building Trust with Care and Long-Term Commitment
MANILA, Philippines, July 25, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science &…
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired…
Huawei Unveils New Products and XMAGE Awards 2025 at Fashion Next Event in Dubai
DUBAI, UAE, July 9, 2025 /PRNewswire/ -- Huawei today announced that it…
Vantage Foundation Joins Hands with KDM Foundation to Empower Street Children in Jakarta
JAKARTA, Indonesian, July 3, 2025 /PRNewswire/ -- In line with its commitment…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes AssociationāsĀ® 85th Scientific Sessions, showed…